TOPIRAMATE | A077627 | GLENMARK PHARMACEUTICALS LTD
Highest NADAC/Unit
$0.1069
per ea
Lowest NADAC/Unit
$0.0254
per ea
Brand NDCs
0
Generic NDCs
11
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68462011060TOPIRAMATE 200 MG TABLET | $0.1069 | EA | Generic | — | 2026-06-17 |
| 68462011010TOPIRAMATE 200 MG TABLET | $0.1069 | EA | Generic | — | 2026-06-17 |
| 68462010960TOPIRAMATE 100 MG TABLET | $0.0580 | EA | Generic | — | 2026-06-17 |
| 68462010905TOPIRAMATE 100 MG TABLET | $0.0580 | EA | Generic | — | 2026-06-17 |
| 68462010910TOPIRAMATE 100 MG TABLET | $0.0580 | EA | Generic | — | 2026-06-17 |
| 68462015360TOPIRAMATE 50 MG TABLET | $0.0345 | EA | Generic | — | 2026-06-17 |
Showing 6 of 11 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.